Optinose (OPTN) PT Lowered to $16 at BMO Capital

March 4, 2021 9:36 AM EST
Get Alerts OPTN Hot Sheet
Price: $3.51 -2.23%

Rating Summary:
    6 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 17 | Down: 13 | New: 41
Trade Now! 
Join SI Premium – FREE
BMO Capital analyst Gary Nachman lowered the price target on Optinose (NASDAQ: OPTN) to $16.00 (from $18.00) while maintaining a Outperform rating.

You May Also Be Interested In





Related Categories

Analyst PT Change